Chemistry and molecular aspects of drug design and action

Saved in:
Bibliographic Details
Other Authors: Rekka, E. A. (Editor), Kourounakis, P. N. (Editor)
Format: Book
Language:English
Published: Boca Raton CRC Press/Taylor & Francis 2008.
Subjects:
Online Access:Table of contents only
Publisher description
View in OPAC
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a22000004a 4500
005 20260127133942.0
008 130620s2008 flua b 001 0 eng
010 |a 2007-010012 
015 |a GBA6A2532  |2 bnb 
016 7 |a 013618958  |2 Uk 
016 7 |a 101301450  |2 DNLM 
020 |a 9780849390067 (hbk. : alk. paper) 
020 |a 0849390060 (hbk. : alk. paper) 
035 |a vtls010521467 
035 |a (OCoLC)ocm76936122 
035 |a (OCoLC)76936122 
035 |a 14764747 
039 9 |y 201306200815  |z mschk03 
040 |a DNLM/DLC  |c DLC  |d DLC  |d STUSCHK1 
042 |a pcc 
060 1 0 |a QV 744  |b C5173 2008 
080 0 0 |a 615/.19  |2 22 
245 0 0 |a Chemistry and molecular aspects of drug design and action  |c edited by E.A. Rekka, P.N. Kourounakis. 
260 |a Boca Raton  |b CRC Press/Taylor & Francis  |c 2008. 
300 |a xxii, 356 p.  |b ill.  |c 25 cm. 
504 |a Includes bibliographical references and index. 
505 0 |a Inflammatory mechanisms in Alzheimer's disease and other neurodegenerative disorders / Joseph Rogers ... [et al.] -- Treatment development strategies for Alzheimer's disease / Ernst Wülfert -- Lipoprotein-associated phospholipase A₂ as a new prognostic factor for coronary artery disease / Alexandros D. Tselepis -- New molecular targets for the prevention and treatment of gastrointestinal ulcers and inflammation / Sandor Szabo ... [et al.] -- Stress activates corticotropin releasing : factor signaling pathways : implication in functional bowel disorders / Yvette Taché -- Design, synthesis, and pharmacological evaluation of high-affinity and selectivity sigma-1 and sigma-2 receptor ligands / Jacques H. Poupaert -- Synthesis of biologically active taxoids / K.C. Nicolaou and R.K. Guy -- From the molecular pharmacology to the medicinal chemistry of cannabinoids / Didier M. Lambert -- An appraisal of fomocaines : current situation and outlook / Herbert Oelschläger and Andreas Seeling -- Ligands for the GABA recognition site at the GABAA receptor : structure-activity studies / Bente Frølund ... [et al.] -- Strategies for development of new lead structures for inhibition of acetylcholinesterase / Petra Kapkova ... [et al.] -- Discovery of potent and selective inhibitors of human aldosterone synthase (CYP11B2) : a new target for the treatment of congestive heart failure and myocardial fibrosis--a review / R.W. Hartmann ... [et al.] -- 
505 0 |a Thiocarboxanilides : a new class of nonnucleoside reverse transcriptase inhibitors (NNRTIs) with great potential for the treatment of human immunodeficiency virus type 1 (HIV-1) infections / E. De Clercq, A. Karlsson, and J. Balzarini -- Histamine H₃-receptor agonists and antagonists : chemical, pharmacological, and clinical aspects / Holger Stark and Walter Schunack -- Anti-inflammatory actions of flavonoids and structural requirements for new design / Theoharis C. Theoharides -- Molecular mechanisms of H₂O₂-induced DNA damage : the action of desferrioxamine / M. Tenopoulou, P.-T Doulias, and D. Galaris -- LNA (locked nucleic acid) and functionalized LNA : towards efficient gene targeting / Jesper Wengel -- The effect of diet on drug metabolism / K.J. Netter -- Cytochromes P450 in the metabolism and bioactivation of chemicals / Costas Ioannides -- In vitro methods to measure drug metabolism and drug interactions in drug discovery and development / O. Pelkonen ... [et al.] -- How to probe the sites of action of drug molecules / A. Makriyannis and F. Bitter -- Physicochemical profiling in early drug discovery : new challenges at the age of high-throughput screen and combinatorial chemistry / Bernard Faller -- Drug membrane interaction and its importance for drug efficacy / J.K. Seydel ... [et al.] -- The fight against AIDS : new avenues for inhibiting reverse transcriptase (RT), and old target / Maurizio Botta ... [et al.]. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Drugs  |x Design. 
650 1 2 |a Chemistry, Pharmaceutical. 
650 2 2 |a Drug Design. 
650 2 2 |a Pharmacologic Actions. 
700 1 |a Rekka, E. A.  |4 edt 
700 1 |a Kourounakis, P. N.  |4 edt. 
856 4 1 |3 Table of contents only  |u http://www.loc.gov/catdir/toc/ecip0712/2007010012.html 
856 4 2 |3 Publisher description  |u http://www.loc.gov/catdir/enhancements/fy0710/2007010012-d.html 
906 |a 7  |b cbc  |c orignew  |d 1  |e ecip  |f 20  |g y-gencatlg 
925 0 |a acquire  |b 2 shelf copies  |x policydefault, Sel/sdb 2008-10-20 
925 1 |a acquire  |b 1 shelf copy  |x policy default 
955 |d jc18 2007-03-12  |e jc18 2007-03-12 to Dewey  |f jx13 2008-06-18 Z-CipVer  |g jx13 2008-06-18 to BCCD 
999 |c 767  |d 767